← Open Payments lookup

GREGORY PANICCIA: Open Payments

NPI 1518022920 · NATIONAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,908 in 240 payments from 14 companies in 2025. Trend: 2023 $3,438 · 2024 $3,068 · 2025 $4,908

Food & beverage: $4,794Education: $114
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.43$823
Alkermes, Inc.36$693
Otsuka America Pharmaceutical, Inc.29$665
ABBVIE INC.26$529
Teva Pharmaceuticals USA, Inc.22$512
E.R. Squibb & Sons, L.L.C.25$388
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$351
Vanda Pharmaceuticals Inc.13$278
Janssen Pharmaceuticals, Inc12$231
Lundbeck LLC10$213

Products named: INGREZZA, REXULTI, ARISTADA, VRAYLAR, COBENFY, CAPLYTA, UZEDY, FANAPT.

Industry payments across CA — which companies pay providers there.